nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—Cardiogenic shock—Epirubicin—bone cancer	0.0287	0.0297	CcSEcCtD
Atenolol—Cardiogenic shock—Doxorubicin—bone cancer	0.0265	0.0275	CcSEcCtD
Atenolol—Alopecia reversible—Epirubicin—bone cancer	0.0265	0.0274	CcSEcCtD
Atenolol—Alopecia reversible—Doxorubicin—bone cancer	0.0245	0.0254	CcSEcCtD
Atenolol—Arterial thrombosis—Methotrexate—bone cancer	0.0238	0.0247	CcSEcCtD
Atenolol—Cardiomegaly—Epirubicin—bone cancer	0.0165	0.0171	CcSEcCtD
Atenolol—Cardiomegaly—Doxorubicin—bone cancer	0.0152	0.0158	CcSEcCtD
Atenolol—Pain—Carboplatin—bone cancer	0.0122	0.0126	CcSEcCtD
Atenolol—Wheezing—Cisplatin—bone cancer	0.0114	0.0118	CcSEcCtD
Atenolol—Body temperature increased—Carboplatin—bone cancer	0.0113	0.0117	CcSEcCtD
Atenolol—Psoriasis—Methotrexate—bone cancer	0.0102	0.0106	CcSEcCtD
Atenolol—Psoriasis—Epirubicin—bone cancer	0.00956	0.00991	CcSEcCtD
Atenolol—Cardiac failure congestive—Cisplatin—bone cancer	0.00937	0.00971	CcSEcCtD
Atenolol—Chlorphenesin—CYP3A4—bone cancer	0.00934	0.264	CrCbGaD
Atenolol—Nasal congestion—Cisplatin—bone cancer	0.00932	0.00967	CcSEcCtD
Atenolol—Chlorphenesin—PTGS2—bone cancer	0.00914	0.259	CrCbGaD
Atenolol—Bisoprolol—CYP3A4—bone cancer	0.0091	0.258	CrCbGaD
Atenolol—Amnesia—Cisplatin—bone cancer	0.00904	0.00937	CcSEcCtD
Atenolol—Psoriasis—Doxorubicin—bone cancer	0.00885	0.00917	CcSEcCtD
Atenolol—Rash erythematous—Epirubicin—bone cancer	0.00785	0.00813	CcSEcCtD
Atenolol—Orthostatic hypotension—Cisplatin—bone cancer	0.00776	0.00804	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.00765	0.00793	CcSEcCtD
Atenolol—Rash erythematous—Doxorubicin—bone cancer	0.00726	0.00753	CcSEcCtD
Atenolol—Abdominal discomfort—Cisplatin—bone cancer	0.00704	0.0073	CcSEcCtD
Atenolol—Hepatic enzyme increased—Methotrexate—bone cancer	0.00679	0.00704	CcSEcCtD
Atenolol—Renal failure—Cisplatin—bone cancer	0.00643	0.00667	CcSEcCtD
Atenolol—Myocardial infarction—Cisplatin—bone cancer	0.00642	0.00665	CcSEcCtD
Atenolol—Atrioventricular block—Epirubicin—bone cancer	0.00619	0.00642	CcSEcCtD
Atenolol—Ventricular tachycardia—Epirubicin—bone cancer	0.00601	0.00623	CcSEcCtD
Atenolol—Bradycardia—Cisplatin—bone cancer	0.00598	0.0062	CcSEcCtD
Atenolol—Abnormal dreams—Epirubicin—bone cancer	0.00594	0.00616	CcSEcCtD
Atenolol—Atrioventricular block—Doxorubicin—bone cancer	0.00573	0.00594	CcSEcCtD
Atenolol—Pulmonary oedema—Methotrexate—bone cancer	0.00572	0.00592	CcSEcCtD
Atenolol—Visual impairment—Cisplatin—bone cancer	0.00566	0.00587	CcSEcCtD
Atenolol—Ventricular tachycardia—Doxorubicin—bone cancer	0.00556	0.00576	CcSEcCtD
Atenolol—Dry eye—Epirubicin—bone cancer	0.00555	0.00575	CcSEcCtD
Atenolol—Abnormal dreams—Doxorubicin—bone cancer	0.00549	0.0057	CcSEcCtD
Atenolol—Tinnitus—Cisplatin—bone cancer	0.00548	0.00568	CcSEcCtD
Atenolol—Flushing—Cisplatin—bone cancer	0.00545	0.00565	CcSEcCtD
Atenolol—Pulmonary oedema—Epirubicin—bone cancer	0.00535	0.00554	CcSEcCtD
Atenolol—Arrhythmia—Cisplatin—bone cancer	0.00525	0.00544	CcSEcCtD
Atenolol—Alopecia—Cisplatin—bone cancer	0.00519	0.00538	CcSEcCtD
Atenolol—Dry eye—Doxorubicin—bone cancer	0.00514	0.00532	CcSEcCtD
Atenolol—Pulmonary oedema—Doxorubicin—bone cancer	0.00495	0.00513	CcSEcCtD
Atenolol—Dermatitis exfoliative—Methotrexate—bone cancer	0.00494	0.00512	CcSEcCtD
Atenolol—Visual disturbance—Methotrexate—bone cancer	0.00492	0.0051	CcSEcCtD
Atenolol—Vascular purpura—Epirubicin—bone cancer	0.00488	0.00505	CcSEcCtD
Atenolol—Vision blurred—Cisplatin—bone cancer	0.00482	0.005	CcSEcCtD
Atenolol—Cardiac failure congestive—Epirubicin—bone cancer	0.00481	0.00499	CcSEcCtD
Atenolol—Lethargy—Methotrexate—bone cancer	0.00476	0.00493	CcSEcCtD
Atenolol—Ill-defined disorder—Cisplatin—bone cancer	0.00475	0.00492	CcSEcCtD
Atenolol—Hot flush—Epirubicin—bone cancer	0.00466	0.00483	CcSEcCtD
Atenolol—Dermatitis exfoliative—Epirubicin—bone cancer	0.00462	0.00479	CcSEcCtD
Atenolol—Menopausal symptoms—Epirubicin—bone cancer	0.00462	0.00479	CcSEcCtD
Atenolol—Malaise—Cisplatin—bone cancer	0.00461	0.00478	CcSEcCtD
Atenolol—Purpura—Epirubicin—bone cancer	0.00453	0.00469	CcSEcCtD
Atenolol—Vascular purpura—Doxorubicin—bone cancer	0.00451	0.00468	CcSEcCtD
Atenolol—Cardiac failure—Epirubicin—bone cancer	0.00447	0.00463	CcSEcCtD
Atenolol—Lethargy—Epirubicin—bone cancer	0.00445	0.00461	CcSEcCtD
Atenolol—Cardiac failure congestive—Doxorubicin—bone cancer	0.00445	0.00461	CcSEcCtD
Atenolol—Mood swings—Methotrexate—bone cancer	0.00442	0.00458	CcSEcCtD
Atenolol—Ataxia—Methotrexate—bone cancer	0.00438	0.00454	CcSEcCtD
Atenolol—Pain in extremity—Epirubicin—bone cancer	0.00436	0.00452	CcSEcCtD
Atenolol—Anxiety—Cisplatin—bone cancer	0.00434	0.0045	CcSEcCtD
Atenolol—Hot flush—Doxorubicin—bone cancer	0.00431	0.00447	CcSEcCtD
Atenolol—Discomfort—Cisplatin—bone cancer	0.0043	0.00446	CcSEcCtD
Atenolol—Affect lability—Epirubicin—bone cancer	0.00429	0.00445	CcSEcCtD
Atenolol—Menopausal symptoms—Doxorubicin—bone cancer	0.00428	0.00443	CcSEcCtD
Atenolol—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00428	0.00443	CcSEcCtD
Atenolol—Purpura—Doxorubicin—bone cancer	0.00419	0.00434	CcSEcCtD
Atenolol—Oedema—Cisplatin—bone cancer	0.00417	0.00433	CcSEcCtD
Atenolol—Cardiac arrest—Epirubicin—bone cancer	0.00415	0.0043	CcSEcCtD
Atenolol—Cardiac failure—Doxorubicin—bone cancer	0.00414	0.00429	CcSEcCtD
Atenolol—Mood swings—Epirubicin—bone cancer	0.00413	0.00428	CcSEcCtD
Atenolol—Lethargy—Doxorubicin—bone cancer	0.00412	0.00427	CcSEcCtD
Atenolol—Ataxia—Epirubicin—bone cancer	0.0041	0.00425	CcSEcCtD
Atenolol—Thrombocytopenia—Cisplatin—bone cancer	0.00409	0.00424	CcSEcCtD
Atenolol—Ibuprofen—PTGS2—bone cancer	0.00408	0.116	CrCbGaD
Atenolol—Tachycardia—Cisplatin—bone cancer	0.00407	0.00422	CcSEcCtD
Atenolol—Pain in extremity—Doxorubicin—bone cancer	0.00404	0.00418	CcSEcCtD
Atenolol—Hyperhidrosis—Cisplatin—bone cancer	0.00404	0.00418	CcSEcCtD
Atenolol—Orthostatic hypotension—Epirubicin—bone cancer	0.00398	0.00413	CcSEcCtD
Atenolol—Anorexia—Cisplatin—bone cancer	0.00398	0.00413	CcSEcCtD
Atenolol—Affect lability—Doxorubicin—bone cancer	0.00397	0.00412	CcSEcCtD
Atenolol—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00393	0.00407	CcSEcCtD
Atenolol—Hypotension—Cisplatin—bone cancer	0.0039	0.00404	CcSEcCtD
Atenolol—Abdominal discomfort—Methotrexate—bone cancer	0.00386	0.004	CcSEcCtD
Atenolol—Cardiac arrest—Doxorubicin—bone cancer	0.00384	0.00398	CcSEcCtD
Atenolol—Mood swings—Doxorubicin—bone cancer	0.00382	0.00396	CcSEcCtD
Atenolol—Ataxia—Doxorubicin—bone cancer	0.0038	0.00393	CcSEcCtD
Atenolol—Paraesthesia—Cisplatin—bone cancer	0.00375	0.00389	CcSEcCtD
Atenolol—Dyspnoea—Cisplatin—bone cancer	0.00372	0.00386	CcSEcCtD
Atenolol—Erectile dysfunction—Methotrexate—bone cancer	0.00371	0.00385	CcSEcCtD
Atenolol—Orthostatic hypotension—Doxorubicin—bone cancer	0.00369	0.00382	CcSEcCtD
Atenolol—Propranolol—CYP3A4—bone cancer	0.00367	0.104	CrCbGaD
Atenolol—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00363	0.00377	CcSEcCtD
Atenolol—Decreased appetite—Cisplatin—bone cancer	0.00363	0.00376	CcSEcCtD
Atenolol—Gastrointestinal disorder—Cisplatin—bone cancer	0.0036	0.00374	CcSEcCtD
Atenolol—Drowsiness—Methotrexate—bone cancer	0.00359	0.00372	CcSEcCtD
Atenolol—Depression—Methotrexate—bone cancer	0.00358	0.00371	CcSEcCtD
Atenolol—Pain—Cisplatin—bone cancer	0.00357	0.0037	CcSEcCtD
Atenolol—Renal failure—Methotrexate—bone cancer	0.00353	0.00366	CcSEcCtD
Atenolol—Sweating—Methotrexate—bone cancer	0.00344	0.00357	CcSEcCtD
Atenolol—Feeling abnormal—Cisplatin—bone cancer	0.00344	0.00357	CcSEcCtD
Atenolol—Epistaxis—Methotrexate—bone cancer	0.00339	0.00351	CcSEcCtD
Atenolol—Drowsiness—Epirubicin—bone cancer	0.00336	0.00348	CcSEcCtD
Atenolol—Agranulocytosis—Methotrexate—bone cancer	0.00335	0.00347	CcSEcCtD
Atenolol—Renal failure—Epirubicin—bone cancer	0.0033	0.00343	CcSEcCtD
Atenolol—Body temperature increased—Cisplatin—bone cancer	0.0033	0.00342	CcSEcCtD
Atenolol—Sweating—Epirubicin—bone cancer	0.00322	0.00334	CcSEcCtD
Atenolol—Epistaxis—Epirubicin—bone cancer	0.00317	0.00329	CcSEcCtD
Atenolol—Agranulocytosis—Epirubicin—bone cancer	0.00314	0.00325	CcSEcCtD
Atenolol—Drowsiness—Doxorubicin—bone cancer	0.00311	0.00322	CcSEcCtD
Atenolol—Visual impairment—Methotrexate—bone cancer	0.00311	0.00322	CcSEcCtD
Atenolol—Bradycardia—Epirubicin—bone cancer	0.00307	0.00318	CcSEcCtD
Atenolol—Renal failure—Doxorubicin—bone cancer	0.00306	0.00317	CcSEcCtD
Atenolol—Tinnitus—Methotrexate—bone cancer	0.00301	0.00312	CcSEcCtD
Atenolol—Asthenia—Cisplatin—bone cancer	0.003	0.0031	CcSEcCtD
Atenolol—Sweating—Doxorubicin—bone cancer	0.00298	0.00309	CcSEcCtD
Atenolol—Epistaxis—Doxorubicin—bone cancer	0.00293	0.00304	CcSEcCtD
Atenolol—Visual impairment—Epirubicin—bone cancer	0.00291	0.00301	CcSEcCtD
Atenolol—Agranulocytosis—Doxorubicin—bone cancer	0.0029	0.00301	CcSEcCtD
Atenolol—Diarrhoea—Cisplatin—bone cancer	0.00286	0.00296	CcSEcCtD
Atenolol—Alopecia—Methotrexate—bone cancer	0.00285	0.00295	CcSEcCtD
Atenolol—Bradycardia—Doxorubicin—bone cancer	0.00284	0.00295	CcSEcCtD
Atenolol—Tinnitus—Epirubicin—bone cancer	0.00281	0.00292	CcSEcCtD
Atenolol—Flushing—Epirubicin—bone cancer	0.0028	0.0029	CcSEcCtD
Atenolol—Arrhythmia—Epirubicin—bone cancer	0.0027	0.00279	CcSEcCtD
Atenolol—Visual impairment—Doxorubicin—bone cancer	0.00269	0.00279	CcSEcCtD
Atenolol—Alopecia—Epirubicin—bone cancer	0.00267	0.00276	CcSEcCtD
Atenolol—Vision blurred—Methotrexate—bone cancer	0.00265	0.00274	CcSEcCtD
Atenolol—Rash—Cisplatin—bone cancer	0.00263	0.00273	CcSEcCtD
Atenolol—Dermatitis—Cisplatin—bone cancer	0.00263	0.00273	CcSEcCtD
Atenolol—Ill-defined disorder—Methotrexate—bone cancer	0.0026	0.0027	CcSEcCtD
Atenolol—Tinnitus—Doxorubicin—bone cancer	0.0026	0.0027	CcSEcCtD
Atenolol—Flushing—Doxorubicin—bone cancer	0.00259	0.00269	CcSEcCtD
Atenolol—Tension—Epirubicin—bone cancer	0.00258	0.00267	CcSEcCtD
Atenolol—Nervousness—Epirubicin—bone cancer	0.00255	0.00264	CcSEcCtD
Atenolol—Malaise—Methotrexate—bone cancer	0.00253	0.00262	CcSEcCtD
Atenolol—Vertigo—Methotrexate—bone cancer	0.00252	0.00261	CcSEcCtD
Atenolol—Arrhythmia—Doxorubicin—bone cancer	0.00249	0.00259	CcSEcCtD
Atenolol—Nausea—Cisplatin—bone cancer	0.00248	0.00257	CcSEcCtD
Atenolol—Vision blurred—Epirubicin—bone cancer	0.00248	0.00257	CcSEcCtD
Atenolol—Alopecia—Doxorubicin—bone cancer	0.00247	0.00256	CcSEcCtD
Atenolol—Cough—Methotrexate—bone cancer	0.00245	0.00254	CcSEcCtD
Atenolol—Ill-defined disorder—Epirubicin—bone cancer	0.00244	0.00253	CcSEcCtD
Atenolol—Chest pain—Methotrexate—bone cancer	0.00239	0.00248	CcSEcCtD
Atenolol—Tension—Doxorubicin—bone cancer	0.00239	0.00247	CcSEcCtD
Atenolol—Malaise—Epirubicin—bone cancer	0.00237	0.00246	CcSEcCtD
Atenolol—Discomfort—Methotrexate—bone cancer	0.00236	0.00245	CcSEcCtD
Atenolol—Nervousness—Doxorubicin—bone cancer	0.00236	0.00245	CcSEcCtD
Atenolol—Vertigo—Epirubicin—bone cancer	0.00236	0.00245	CcSEcCtD
Atenolol—Syncope—Epirubicin—bone cancer	0.00236	0.00244	CcSEcCtD
Atenolol—Palpitations—Epirubicin—bone cancer	0.00232	0.00241	CcSEcCtD
Atenolol—Confusional state—Methotrexate—bone cancer	0.00231	0.00239	CcSEcCtD
Atenolol—Loss of consciousness—Epirubicin—bone cancer	0.00231	0.00239	CcSEcCtD
Atenolol—Cough—Epirubicin—bone cancer	0.00229	0.00238	CcSEcCtD
Atenolol—Vision blurred—Doxorubicin—bone cancer	0.00229	0.00237	CcSEcCtD
Atenolol—Ill-defined disorder—Doxorubicin—bone cancer	0.00226	0.00234	CcSEcCtD
Atenolol—Thrombocytopenia—Methotrexate—bone cancer	0.00224	0.00233	CcSEcCtD
Atenolol—Chest pain—Epirubicin—bone cancer	0.00224	0.00232	CcSEcCtD
Atenolol—Anxiety—Epirubicin—bone cancer	0.00223	0.00231	CcSEcCtD
Atenolol—Hyperhidrosis—Methotrexate—bone cancer	0.00221	0.0023	CcSEcCtD
Atenolol—Discomfort—Epirubicin—bone cancer	0.00221	0.00229	CcSEcCtD
Atenolol—Malaise—Doxorubicin—bone cancer	0.00219	0.00227	CcSEcCtD
Atenolol—Dry mouth—Epirubicin—bone cancer	0.00219	0.00227	CcSEcCtD
Atenolol—Vertigo—Doxorubicin—bone cancer	0.00218	0.00226	CcSEcCtD
Atenolol—Anorexia—Methotrexate—bone cancer	0.00218	0.00226	CcSEcCtD
Atenolol—Syncope—Doxorubicin—bone cancer	0.00218	0.00226	CcSEcCtD
Atenolol—Confusional state—Epirubicin—bone cancer	0.00216	0.00224	CcSEcCtD
Atenolol—Palpitations—Doxorubicin—bone cancer	0.00215	0.00223	CcSEcCtD
Atenolol—Oedema—Epirubicin—bone cancer	0.00214	0.00222	CcSEcCtD
Atenolol—Hypotension—Methotrexate—bone cancer	0.00214	0.00222	CcSEcCtD
Atenolol—Loss of consciousness—Doxorubicin—bone cancer	0.00214	0.00221	CcSEcCtD
Atenolol—Cough—Doxorubicin—bone cancer	0.00212	0.0022	CcSEcCtD
Atenolol—Shock—Epirubicin—bone cancer	0.00211	0.00219	CcSEcCtD
Atenolol—Thrombocytopenia—Epirubicin—bone cancer	0.0021	0.00218	CcSEcCtD
Atenolol—Tachycardia—Epirubicin—bone cancer	0.00209	0.00217	CcSEcCtD
Atenolol—Hyperhidrosis—Epirubicin—bone cancer	0.00207	0.00215	CcSEcCtD
Atenolol—Insomnia—Methotrexate—bone cancer	0.00207	0.00215	CcSEcCtD
Atenolol—Chest pain—Doxorubicin—bone cancer	0.00207	0.00215	CcSEcCtD
Atenolol—Anxiety—Doxorubicin—bone cancer	0.00206	0.00214	CcSEcCtD
Atenolol—Paraesthesia—Methotrexate—bone cancer	0.00206	0.00213	CcSEcCtD
Atenolol—Discomfort—Doxorubicin—bone cancer	0.00204	0.00212	CcSEcCtD
Atenolol—Anorexia—Epirubicin—bone cancer	0.00204	0.00212	CcSEcCtD
Atenolol—Dyspnoea—Methotrexate—bone cancer	0.00204	0.00212	CcSEcCtD
Atenolol—Somnolence—Methotrexate—bone cancer	0.00204	0.00211	CcSEcCtD
Atenolol—Dry mouth—Doxorubicin—bone cancer	0.00202	0.0021	CcSEcCtD
Atenolol—Dyspepsia—Methotrexate—bone cancer	0.00202	0.00209	CcSEcCtD
Atenolol—Hypotension—Epirubicin—bone cancer	0.002	0.00208	CcSEcCtD
Atenolol—Confusional state—Doxorubicin—bone cancer	0.002	0.00207	CcSEcCtD
Atenolol—Decreased appetite—Methotrexate—bone cancer	0.00199	0.00206	CcSEcCtD
Atenolol—Oedema—Doxorubicin—bone cancer	0.00198	0.00206	CcSEcCtD
Atenolol—Gastrointestinal disorder—Methotrexate—bone cancer	0.00198	0.00205	CcSEcCtD
Atenolol—Fatigue—Methotrexate—bone cancer	0.00198	0.00205	CcSEcCtD
Atenolol—Pain—Methotrexate—bone cancer	0.00196	0.00203	CcSEcCtD
Atenolol—Shock—Doxorubicin—bone cancer	0.00195	0.00202	CcSEcCtD
Atenolol—Thrombocytopenia—Doxorubicin—bone cancer	0.00194	0.00201	CcSEcCtD
Atenolol—Insomnia—Epirubicin—bone cancer	0.00194	0.00201	CcSEcCtD
Atenolol—Tachycardia—Doxorubicin—bone cancer	0.00194	0.00201	CcSEcCtD
Atenolol—Paraesthesia—Epirubicin—bone cancer	0.00193	0.002	CcSEcCtD
Atenolol—Hyperhidrosis—Doxorubicin—bone cancer	0.00192	0.00199	CcSEcCtD
Atenolol—Dyspnoea—Epirubicin—bone cancer	0.00191	0.00198	CcSEcCtD
Atenolol—Somnolence—Epirubicin—bone cancer	0.00191	0.00198	CcSEcCtD
Atenolol—Anorexia—Doxorubicin—bone cancer	0.00189	0.00196	CcSEcCtD
Atenolol—Feeling abnormal—Methotrexate—bone cancer	0.00189	0.00196	CcSEcCtD
Atenolol—Dyspepsia—Epirubicin—bone cancer	0.00189	0.00196	CcSEcCtD
Atenolol—Decreased appetite—Epirubicin—bone cancer	0.00186	0.00193	CcSEcCtD
Atenolol—Hypotension—Doxorubicin—bone cancer	0.00185	0.00192	CcSEcCtD
Atenolol—Gastrointestinal disorder—Epirubicin—bone cancer	0.00185	0.00192	CcSEcCtD
Atenolol—Fatigue—Epirubicin—bone cancer	0.00185	0.00192	CcSEcCtD
Atenolol—Pain—Epirubicin—bone cancer	0.00183	0.0019	CcSEcCtD
Atenolol—Constipation—Epirubicin—bone cancer	0.00183	0.0019	CcSEcCtD
Atenolol—Body temperature increased—Methotrexate—bone cancer	0.00181	0.00188	CcSEcCtD
Atenolol—Insomnia—Doxorubicin—bone cancer	0.00179	0.00186	CcSEcCtD
Atenolol—Paraesthesia—Doxorubicin—bone cancer	0.00178	0.00185	CcSEcCtD
Atenolol—Dyspnoea—Doxorubicin—bone cancer	0.00177	0.00183	CcSEcCtD
Atenolol—Feeling abnormal—Epirubicin—bone cancer	0.00177	0.00183	CcSEcCtD
Atenolol—Somnolence—Doxorubicin—bone cancer	0.00176	0.00183	CcSEcCtD
Atenolol—Dyspepsia—Doxorubicin—bone cancer	0.00175	0.00181	CcSEcCtD
Atenolol—Decreased appetite—Doxorubicin—bone cancer	0.00172	0.00179	CcSEcCtD
Atenolol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00171	0.00178	CcSEcCtD
Atenolol—Fatigue—Doxorubicin—bone cancer	0.00171	0.00177	CcSEcCtD
Atenolol—Pain—Doxorubicin—bone cancer	0.0017	0.00176	CcSEcCtD
Atenolol—Constipation—Doxorubicin—bone cancer	0.0017	0.00176	CcSEcCtD
Atenolol—Body temperature increased—Epirubicin—bone cancer	0.00169	0.00176	CcSEcCtD
Atenolol—Asthenia—Methotrexate—bone cancer	0.00164	0.0017	CcSEcCtD
Atenolol—Feeling abnormal—Doxorubicin—bone cancer	0.00163	0.00169	CcSEcCtD
Atenolol—Pruritus—Methotrexate—bone cancer	0.00162	0.00168	CcSEcCtD
Atenolol—Body temperature increased—Doxorubicin—bone cancer	0.00157	0.00163	CcSEcCtD
Atenolol—Diarrhoea—Methotrexate—bone cancer	0.00157	0.00162	CcSEcCtD
Atenolol—Asthenia—Epirubicin—bone cancer	0.00154	0.00159	CcSEcCtD
Atenolol—Pruritus—Epirubicin—bone cancer	0.00152	0.00157	CcSEcCtD
Atenolol—Dizziness—Methotrexate—bone cancer	0.00151	0.00157	CcSEcCtD
Atenolol—Diarrhoea—Epirubicin—bone cancer	0.00147	0.00152	CcSEcCtD
Atenolol—Rash—Methotrexate—bone cancer	0.00144	0.0015	CcSEcCtD
Atenolol—Dermatitis—Methotrexate—bone cancer	0.00144	0.0015	CcSEcCtD
Atenolol—Headache—Methotrexate—bone cancer	0.00144	0.00149	CcSEcCtD
Atenolol—Asthenia—Doxorubicin—bone cancer	0.00142	0.00148	CcSEcCtD
Atenolol—Dizziness—Epirubicin—bone cancer	0.00142	0.00147	CcSEcCtD
Atenolol—Pruritus—Doxorubicin—bone cancer	0.0014	0.00145	CcSEcCtD
Atenolol—Nausea—Methotrexate—bone cancer	0.00136	0.00141	CcSEcCtD
Atenolol—Diarrhoea—Doxorubicin—bone cancer	0.00136	0.00141	CcSEcCtD
Atenolol—Rash—Epirubicin—bone cancer	0.00135	0.0014	CcSEcCtD
Atenolol—Dermatitis—Epirubicin—bone cancer	0.00135	0.0014	CcSEcCtD
Atenolol—Headache—Epirubicin—bone cancer	0.00134	0.00139	CcSEcCtD
Atenolol—Dizziness—Doxorubicin—bone cancer	0.00131	0.00136	CcSEcCtD
Atenolol—Nausea—Epirubicin—bone cancer	0.00127	0.00132	CcSEcCtD
Atenolol—Rash—Doxorubicin—bone cancer	0.00125	0.0013	CcSEcCtD
Atenolol—Dermatitis—Doxorubicin—bone cancer	0.00125	0.0013	CcSEcCtD
Atenolol—Headache—Doxorubicin—bone cancer	0.00124	0.00129	CcSEcCtD
Atenolol—Nausea—Doxorubicin—bone cancer	0.00118	0.00122	CcSEcCtD
